PCVX Stock-Based Compensation
Vaxcyte Inc · Stock-Based Compensation
PCVX Stock-Based Compensation
Latest reported$188.47Mperiod ending
PCVX TTM Stock-Based Comp ($1.19M → $188.47M)
TTM stock-based compensation
High-resolution chart · PNG
PCVX stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 188,472,000 | |
| 146,194,000 | |
| 138,845,000 | |
| 127,218,000 | |
| 113,177,000 | |
| 97,808,000 | |
| 84,822,000 | |
| 73,800,000 | |
| 65,755,000 | |
| 56,741,000 | |
| 48,760,000 | |
| 42,421,000 | |
| 35,849,000 | |
| 29,199,000 | |
| 23,650,000 | |
| 19,799,000 | |
| 16,088,000 | |
| 12,963,000 | |
| 10,729,000 | |
| 9,506,000 | |
| 8,407,000 | |
| 6,927,000 | |
| 5,434,000 | |
| 3,874,000 | |
| 2,301,000 | |
| 1,291,000 | |
| 1,185,000 |